Gainers
-
DropCar, Inc. (NASDAQ: DCAR) shares rose 27.6
percent to $2.45 in pre-market trading after the company issued a preliminary Q1 update on its enterprise automotive business.
The company disclosed that Q1 B2B automotive volumes rose 163 percent year-over-year.
-
New Age Beverages Corporation (NASDAQ: NBEV) rose
20.7 percent to $2.33 in pre-market trading after reporting FY17 results.
-
Calithera Biosciences, Inc. (NASDAQ: CALA) rose
15 percent to $7.30 in pre-market trading after the company disclosed that the FDA has granted Fast Track designation to CB-839
in combination with cabozantinib for treatment of patients with advanced renal cell carcinoma.
-
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) rose
14.4 percent to $4.70 in pre-market trading following announcement of the FDA approval for TAVALISSE.
-
Teligent, Inc. (NASDAQ: TLGT) shares rose 12.6
percent to $3.40 in pre-market trading following the FDA approval of Clobetasol Propionate Cream USP, 0.05%.
-
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV)
shares rose 6.4 percent to $10 in pre-market trading after climbing 13.08 percent on Tuesday.
-
Golden Ocean Group Limited (NASDAQ: GOGL) shares
rose 5.6 percent to $8.45 in pre-market trading after gaining 2.17 percent on Tuesday.
-
China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) rose 5.3 percent to $22.97 in pre-market trading after surging 22.65
percent on Tuesday.
-
Semiconductor Manufacturing International Corporation (NYSE: SMI) rose 5.2 percent to $6.50 in pre-market trading after falling 0.80 percent on
Tuesday.
-
Sibanye Gold Limited (NYSE: SBGL) rose 5.2 percent
to $3.55 in pre-market trading after dropping 4.53 percent on Tuesday.
-
eBay Inc. (NASDAQ: EBAY) rose 4.6 percent to
$42.49 in pre-market trading. Morgan Stanley upgraded ebay to Overweight from Underweight.
-
Textron Inc. (NYSE: TXT) shares rose 4.4 percent to
$62.56 in the pre-market trading session after the company reported stronger-than-expected earnings for its first quarter.
-
CSX Corporation (NASDAQ: CSX) rose 4.3 percent to
$59.01 in pre-market trading after reporting upbeat quarterly earnings.
-
United Continental Holdings, Inc. (NYSE: UAL) rose
3.2 percent to $69.51 in pre-market trading after the company reported better-than-expected earnings for its first quarter.
-
Intuitive Surgical, Inc. (NASDAQ: ISRG) rose 3.1
percent to $449.00 in pre-market trading after the company reported stronger-than-expected results for its first quarter.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and
losers
Losers
-
ADTRAN, Inc. (NASDAQ: ADTN) fell 9.1 percent to
$14.60 in pre-market trading after the company reported Q1 earnings.
-
Badger Meter, Inc. (NYSE: BMI) fell 6.7 percent to
$43 in pre-market trading after reporting downbeat quarterly results.
-
Lam Research Corporation (NASDAQ: LRCX) fell 5.3
percent to $201.19 in pre-market trading despite a third quarter earnings beat. The company sees fourth quarter EPS of
$4.80-$5.20 and sales of $2.85 billion-$3.15 billion.
-
International Business Machines Corporation (NYSE: IBM) shares fell 5.3 percent to $152.50 in pre-market trading despite reporting a
first quarter earnings beat. The company reaffirmed its FY18 outlook of EPS of at least $13.80 and free cash flow of $12
billion.
-
Healthcare Services Group, Inc. (NASDAQ: HCSG)
shares fell 4.7 percent to $38.68 in pre-market trading after reporting Q1 results.
-
Endo International plc (NASDAQ: ENDP) fell 4.3
percent to $5.32 in pre-market trading. Endo disclosed that it has received a notification advising that Eagle Pharma has
submitted an ANDA to the FDA seeking approval for a generic version of Vasostrict.
-
Intelsat S.A. (NYSE: I) fell 3.6 percent to $8.78 in
pre-market trading. Intelsat is expected to release Q1 results on May 1, 2018.
-
Exact Sciences Corporation (NASDAQ: EXAS) shares
fell 3.5 percent to $46.02 in pre-market trading after rising 6.24 percent on Tuesday.
-
Zillow Group, Inc. (NASDAQ: Z) fell 3 percent to $
48.20 in pre-market trading.
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.